Inventor
KETCHAM JOHN MICHAEL
US22 patents
⚠️ This page may combine multiple inventors who share the name “KETCHAM JOHN MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MIRATI THERAPEUTICS INC
14 patentsUS11453683B1Sep 27, 2022
KRas G12D inhibitors
MIRATI THERAPEUTICS INC13 citations83
US11091495B2Aug 17, 2021
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC4 citations82
US10647715B2May 12, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC10 citations82
US11964989B2Apr 23, 2024
KRas G12D inhibitors
MIRATI THERAPEUTICS INC2 citations71
US11220509B2Jan 11, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC2 citations71
US12371435B2Jul 29, 2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US12304915B2May 20, 2025
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11702418B2Jul 18, 2023
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11492351B2Nov 8, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11485738B2Nov 1, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11479551B2Oct 25, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC1 citations61
US12421228B2Sep 23, 2025
Naphthyridine derivatives as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations51
US12252493B2Mar 18, 2025
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
MIRATI THERAPEUTICS INC0 citations51
US12280055B2Apr 22, 2025
Combination therapies
MIRATI THERAPEUTICS INC0 citations49
RAPT THERAPEUTICS INC
5 patentsUS10683280B2Jun 16, 2020
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC8 citations82
US11384064B2Jul 12, 2022
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC3 citations71
US11192879B2Dec 7, 2021
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC3 citations71
US10604526B2Mar 31, 2020
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC2 citations71
US12098139B2Sep 24, 2024
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC0 citations60
FLX BIO INC
3 patentsUS10246462B2Apr 2, 2019
Chemokine receptor modulators and uses thereof
FLX BIO INC10 citations80
US10179787B2Jan 15, 2019
Chemokine receptor modulators and uses thereof
FLX BIO INC5 citations69
US10722514B2Jul 28, 2020
Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
FLX BIO INC2 citations57